Follicular development and oocyte maturation in hypogonadotrophic women employing recombinant follicle-stimulating hormone: The role of oestradiol

Human Reproduction Update

Volumn 3, Issue 2, 1997, Pages 101-108

  Fauser, Bart C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Follicular development; Hypogonadotrophic women; Oestradiol; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ENZYME DEFECT; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; FERTILIZATION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; OOCYTE; OOCYTE MATURATION; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION INDUCTION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW;

ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MODELS, BIOLOGICAL; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION; RECOMBINANT PROTEINS;

EID: 0030840533     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/3.2.101     Document Type: Review

References (57)

1. Ben-Chetrit, A., Gotlieb, L., Wong, P.Y. and Casper, R.F. (1996) Ovarian response to recombinant human follicle-stimulating hormone in luteinizing hormone-depleted women: examination of the two cell, two gonadotrophin theory. Fertil. Steril, et al., 65, 711-717.
2. Berger, M.J. and Taymor, M.L. (1971) The role of luteinizing hormone in human follicular maturation and function. Am. J. Obstet. Gynecol., 111, 708-712.
3. Chappel, S.C. and Howles, C. (1991) Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum. Reprod., 6, 1206-1212.
4. Coelingh Bennink, H.J.T., Bouchard, P., DeVroey, P. et al. (1994) Potential clinical applications of recombinant FSH. In Filicori, M. and Flamigni, C. (eds), Ovulation Induction: Basic Science and Clinical Advances. Excerpta Medica Int Congress Series 1064, Elsevier, Amsterdam, The Netherlands, pp. 219-225.
5. Couzinet, B., Lestrat, N., Brailly, S. et al. (1988) Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotrophin deficiency. J. Clin. Endocrinol. Metab., 66, 552-556.
6. Daya, S., Gunby, J., Hughes, E.G. et al. (1995) Follicle-stimulating hormone versus human menopausal gonadotrophin for in vitro fertilization: a meta-analysis. Fertil. Steril., 64, 347-354.
7. DeVroey, P., Mannaerts, B., Smitz, J. et al.. (1994) Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. Hum. Reprod., 9, 1064-1069.
8. DeVroey, P., Van Steirteghem, A., Mannaerts, B. and Bennink, H.C. (1992) Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet, 339, 1170
9. Donderwinkel, P.F., Schoot, D.C., Coelingh Bennink, H.J. and Fauser, B.C. (1992) Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome. Lancet, 340, 983
10. Doody, K.J., Lorence, M.C., Mason, J.I. and Simpson, E.R. (1990) Expression of mRNA species encoding steroidogenic enzymes in human follicles and corpora lutea throughout the menstrual cycle. J. Clin. Endocrinol. Metab., 70, 1041-1045.
11. Ellenbogen, A., Rosenberg, R., Shulman, A. et al. (1996) A follicular scoring system for monitoring ovulation induction in polycystic ovary syndrome patients based solely on ultrasonographic estimation of follicular development. Fertil. Steril., 65, 1175-1177.
12. Eshkol, A. and Lunenfeld, B. (1967) Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human menopausal gonadotrophin (HMG) 3. Effects of a biologically apparently pure FSH preparation on ovaries and uteri of intact, immature mice. Acta Endocrinol. (Copenh), 54, 91-95.
13. Fauser, B.C.J.M. (1996) Interference with follicle-stimulating hormone regulation of human ovarian function. Mol. Hum. Reprod., 2, 327-334.
14. Fauser, B.C.J.M. and Hsueh, A.J.W. (1995) Genetic basis of human reproductive endocrine disorders. Hum. Reprod., 10, 826-846.
15. Fauser, B.C.J.M. and van Heusden, A.M. (1997) Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr. Rev., 18, 71-106.
16. Fevold, H.L. (1941) Synergism of follicle stimulating and luteinising hormone in producing oestradiol secretion. J. Clin. Endocrinol. Metab., 21, 33-36.
17. Germond, M., Dessole, S., Senn, A. et al. (1992) Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. Lancet, 339, 1170
18. Greep, R.O., v Dyke, H.B. and Chow, B.F. (1942) Gonadotropins of the swine pituitary. I. Various biological effects of purified thylakenstrin (FSH) and pure metakentrin (ICSH). Endocrinology, 30, 635-649.
19. Howles, C.M., Loumaye, E., Giroud, D. and Luyet, G. (1994) Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study. Hum. Reprod., 9, 424-430.
20. Hsueh, A.J., Adashi, E.Y., Jones, P.B. and Welsh, T.H.J. (1984) Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocr. Rev., 5, 76-127.
21. Hull, M., Corrigan, E., Piazzi, A. and Loumaye, E. (1994) Recombinant human luteinising hormone: an effective new gonadotrophin preparation. Lancet, 344, 334-335.
22. Hull, M.E., Moghissi, K.S., Magyar, D.M. et al. (1986) Correlation of serum estradiol levels and ultrasound monitoring to assess follicular maturation. Fertil. Steril., 46, 42-45.
23. Hull, M.G.R., Armatage, R.J. and McDermott, A. (1994) Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil. Steril, 62, 997-1003.
24. Karnitis, V.J., Townson, D.H., Friedman, C.I. and Danforth, D.R. (1994) Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotrophin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis. J. Clin. Endocrinol. Metab., 79, 91-97.
25. Keene, J.L., Matzuk, M.M., Otani, T. et al. (1989) Expression of biologically active human follitropin in Chinese hamster ovary cells. J. Biol. Chem., 264, 4769-4775.
26. Kliesch, S., Behre, H.M. and Nieschlag, E. (1995) Recombinant human follicle-stimulating hormone and human chorionic gonadotrophin for induction of spermatogenesis in a hypogonadotropic male. Fertil. Steril., 63, 1326-1328.
27. Kousta, E., White, D.M., Piazzi, A., Loumaye, E. and Franks, S. (1996) Successful induction of ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome. Hum. Reprod., 11, 70-71.
28. Latronico, A.C., Anasti, J., Arnhold, I.J. et al. (1996) Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N. Engl. J. Med., 334, 507-512.
29. Loumaye, E., Campbell, R. and Salat-Baroux, J. (1995) Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum. Reprod. Update, 1, 188-199.
30. Magoffin, D.A., Kurtz, K.M. and Erickson, G.F. (1990) Insulin-like growth factor 1 selectively stimulates cholesterol side chain cleavage expression in ovarian theca-interstitial cells. Mol. Endocrinol., 4, 489-496.
31. Mannaerts, B., De Leeuw, R., Geelen, J. et al. (1991) Comparative in vitro and in vivo studies on the biological characteristics of recombinant human FSH. Endocrinology, 129, 2623-2630.
32. Mannaerts, B., Uilenbroek, J., Schot, P. and De Leeuw, R. (1994) Folliculogenesis in hypophysectomized rats after treatment with recombinant human follicle-stimulating hormone. Biol. Reprod., 51, 72-81.
33. Mannaerts, B.M., Rombout, F., Out, H.J. and Coelingh Bennink, H.J. (1996) Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Hum. Reprod. Update, 2, 153-161.
34. Out, H.J., Mannaerts, B.M., Driessen, S.G. and Coelingh Bennink, H.J. (1995) A prospective, randomized, assessor blind, multicenter study comparing recombinant and urinary follicle-stimulating hormone in in vitro fertilization. Hum. Reprod., 10, 2534-2540.
35. Pellicer, A., Valbuena, D., Cano, F., Remohi, J. and Simon, C. (1996) Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil. Steril., 65, 1190-1195.
36. Recombinant Human FSH Study Group (1995) Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil. Steril., 63, 77-86.
37. Remorgida, V., Venturini, P.L., Anserini, P. et al.. (1989) Administration of pure follicle-stimulating hormone during gonadotrophin-releasing hormone agonist therapy in patients with clomiphene-resistant polycystic ovarian disease: hormonal evaluations and clinical perspectives. Am. J. Obstet. Gynecol., 160, 108-113.
38. Rodgers, M., McLoughlin, J., Peers, N. et al.. (1994) Accumulation of human chorionic gonadotrophin in the serum of patients during in-vitro fertilization treatment cycles with Pergonal. Hum. Reprod., 9, 638-642.
39. Ryan, K.J., Petro, Z. and Kaiser, J. (1968) Steroid formation by isolated and recombined ovarian granulosa and thecal cells. J. Clin. Endocrinol. Metab., 28, 355-358.
40. 17I-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J. Reprod. Fertil, 85, 163-169.
41. Schoot, D.C. and Fauser, B.C.J.M. (1992) Monitoring of follicular development during induction of ovulation using exogenous gonadotrophins. Exp. Clin. Endocrinol., 11, 303-306.
42. Schoot, B.C., Coelingh Bennink, H.J., Mannaerts, B.M. et al. (1992) Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotrophin deficiency. J. Clin. Endocrinol. Metab., 74, 1471-1473.
43. Schoot, D.C., Harlin, J., Shoham, Z. et al. (1994) Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum. Reprod., 9, 1237-1242.
44. Schoot, D.C., Hop, W.C.J., De Jong, F.H. et al. (1995) Initial estradiol response predicts outcome of exogenous gonadotrophins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome. Fertil. Steril, 64, 1081-1087.
45. Shoham, Z., Balen, A., Patel, A. and Jacobs, H.S. (1991) Results of ovulation induction using human menopausal gonadotrophin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil. Steril., 56, 1048-1053.
46. Shoham, Z., Mannaerts, B., Insler, V. and Coelingh-Bennink, H. (1993) Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil. Steril., 59, 738-742.
47. Simon, C., Cano, F., Valbuena, D. et al. (1995) Clinical evidence for detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal response patients. Hum. Reprod., 10, 2432-2437.
48. Smyth, C.D., Miró, F., Whitelaw, P.F. et al. (1993) Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology, 133, 1532-1538.
49. Stokman, P.G., De Leeuw, R., vd Wijngaard, H.A. et al. (1993) Human chorionic gonadotrophin in commercial human menopausal gonadotrophin preparations. Fertil. Steril., 60, 175-178.
50. Suzuki, T., Sasano, H., Tamura, M. et al. (1993) Temporal and spatial localization of steroidogenic enzymes in premenopausal human ovaries: in situ hybridization and immunohistochemical study. Mol. Cell Endocrinol., 97, 135-143.
51. Toledo, S.P., Brunner, H.G., Kraaij, R. et al. (1996) An inactivating mutation of the LH receptor causes amenorrhea in a 46 XX female. J. Clin. Endocrinol. Metab., 81, 3850-3854.
52. Tsang, B.K., Armstrong, D.T. and Whilfield, J.F. (1980) Steroid biosynthesis by isolated human ovarian follicular cells in vitro. J. Clin. Endocrinol. Metab., 51, 1407-1411.
53. van Dessel, H.J.H.M., Schipper, I., Pache, T.D. et al. (1996a) Normal human follicle development an evaluation of correlations wilh oestradiol androstenedione and progesterone levels in individual follicles. Clin. Endocrinol. (Oxf.), 44, 191-198.
54. van Dessel, H.J.H.M., Schoot, B.C., Schipper, J. et al. (1996b) Circulating immunoreactive and bioactive serum follicle-stimulating hormone levels in normogonadotropic anovulatory infertile women and during gonadotrophin induction of ovulation applying a decremental dose regimen. Hum. Reprod., 11, 478-485.
55. van Heusden, A.M., Coelingh-Bennink, H.J.T. and Fauser, B.C.J.M. (1994) Comparison of ovarian function after the pill-free interval and following recFSH administration combined with suppression of the pituitary-ovarian axis. Annual Meeting Endocrine Society, Anaheim, Calif., USA, p 412, Abstr 848.
56. Wang, X.N. and Greenwald, G.S. (1993) Human chorionic gonadotrophin or human recombinant follicle-stimulating hormone (FSH)-induced . ovulation and subsequent fertilization and early embryo development in hypophysectomized FSH-primed mice. Endocrinology, 132, 2009-2016.
57. Wikland, M., Borg, J., Hamberger, L. and Svalander, P. (1994) Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Hum. Reprod., 9, 1430-1436.